(All fields required)
Please enter a valid email.
Please enter your name.
The Division of Allergy and Immunology offers information about news coverage and happenings involving members of our division and the Cincinnati Center for Eosinophilic Disorders (CCED).
Integrating Grantseeking and Fundraising
Division Business Director, Kevin Titus, MBA was recently asked for his perspective on the important of integrated strategic planning for the white paper Integrating Grantseeking into Hospital Foundation Fundraising Plans published by Hanover Research.
APFED HOPE Pilot Grant
Ting Wen, PhD was awarded a 2015 APFED HOPE Pilot Grant for his project "Defining Esophageal Lymphocyte Phenotype and Function in Eosinophilic Esophagitis" from the American Partnership for Eosinophilic Disorders (APFED). This award is designed to support the initiation of research that will be the basis of a larger research project within the subspecialty of eosinophilic disorders.
Cincinnati Children's T1 Innovative Core Grant
Artem Barski, PhD and Andrey V. Kartashov, MS were awarded a T1 Innovative Core Grant by Cincinnati Children's for the Wardrobe Server. Wardrobe is a software package for storing and analyzing chromatin immunoprecipiation sequencing, RNA sequencing, and similar datasets. It was collaboratively generated by Barski and Kartashov. Learn more about their research in the Barski Lab.
Simon P. Hogan, PhD was awarded a 2015 FARE Investigator in Food Allergy Award. This Mid-Career Investigator Award from Food Allergy Research & Education (FARE) will support Hogan in identifying the key proteins and cells that cause the blood vessel fluid leak leading to severe anaphylaxis triggered by foods. Learn more about his research in the Hogan Lab.
First-Place Graduate Student Research Forum Poster
Congratulations to Rothenberg Lab member and predoctoral fellow Rahul D'Mello for winning First Place at the 2015 Graduate Student Research Forum poster competition at the University of Cincinnati College of Medicine.
ASCI Young Physician-Scientist Award
Patricia C. Fulkerson, MD, PhD was awarded a 2015 Young Physician-Scientist Award by the American Society for Clinical Investigation. The ASCI Council Young Physician-Scientist Awards recognize early-stage physician-scientists who are early in their first faculty appointment and have made notable achievements in their research. This award provides an honorarium for her to present her research at the ASCI/ American Association of Physicians (AAP) Joint Meeting. Learn more about her research in the Fulkerson Lab.
First-Place DHC Poster
Nurit Azouz, PhD, a research fellow in the Rothenberg Lab, won the first prize for her poster at the 2015 Annual Scientific Symposium by the Digestive Health Center.
New Patient Contact Registry for Rare Eosinophilic Gastrointestinal Diseases
To coincide with Rare Disease Day® 2015, the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) launched a patient contact registry for individuals with eosinophilic gastrointestinal diseases (EGID), a group of rare diseases. Marc Rothenberg, MD, PhD, is the principal investigator of the National Institutes of Health grant that funds the CEGIR (U54 AI117804).
MicroRNA Potential Biomarker for Esophagitis
Faculty member Ting Wen, PhD recently commented in an article discussing microRNA as potential biomarkers for esophagitis.
Mentoring Achievement Award
Our division's Director of Research, Simon P. Hogan, PhD, was recognized for his dedicated efforts with the Mentoring Achievement Award in the Fourth Annual Faculty Awards by Cincinnati Children's.
Patricia C. Fulkerson, MD, PhD, was awarded a Trustee Award by the Trustee Award & Procter Scholar (TAPS) Program at Cincinnati Children's for her project "Role of Helios and Aiolos in Eosinophil Development". Learn more about her research in the Fulkerson Lab.
Carina Venter Joins Cincinnati Center for Eosinophilic Disorders
Carina Venter, PhD, RD, will be joining the Division of Allergy and Immunology and Cincinnati Center for Eosinophilic Disorders (CCED) team at Cincinnati Children's as a research associate in February 2015. Dr. Venter is a dietician who was trained in South Africa and completed her postdoctoral studies in food hypersensitivity in the United Kingdom. Her notable accomplishments are many, including being the first and only dietician ever to be invited to act on many of the Advisory Panels for the Food Standards Agency in the United Kingdom. She comes to us from the University of Portsmouth and Isle of Wight, where she serves academically and clinically as a Senior Lecturer and Specialist Allergy Dietitian. Her research endeavors have received funding from the National Institute for Health Research (U.K.) and industry (Danone, Nutricia). In just the past 5 years (2010-2014), Dr. Venter has authored 25 peer-reviewed publications and 3 book chapters and supervised 14 post-graduate students (9 M.Sc. and 5 Ph.D.). Dr. Venter will be a great asset to the division and CCED team, clinic, research, and patients.
Cincinnati Children’s Receives NIH Grant To Lead Multicenter Consortium on Eosinophilic Disorders
Environment Plays Bigger Role than Genetics in Food Allergic Disease Eosinophilic Esophagitis
Advancing the Understanding of an Understudied Food Allergy Disorder -- Eosinophilic Gastritis
Division Contributes to Peanut Desensitization StudyOur division and center has been on of the top enrolling centers in the multi-center peanut desensitization study using the Viaskin patch. This important clinical research could not have been accomplished without the dedicated efforts and expertise of our clinical research team, led by Amal H. Assa'ad, MD, and the support of the division and the individuals and families who entered the study. DBV technologies, the sponsor of the study, announced in a press release that the primary endpoint for this phase IIb clinical trial has been met.
First Prize PosterCongratulations to faculty member Ting Wen, PhD on winning the first prize poster at the 2014 Ohio River Valley Cytometry Association meeting.
New Study Aims for Quick Suppression of Food Allergies
Studies Show Promise for Treating Troublesome Food Allergy
High-dose Fluticasone Effective Against Eosinophilic Esophagitis
Study Finds Cause of Mysterious Food Allergy, Suggests New Treatment Strategy
Ohio and Israel Sign Joint R&D Agreement
Frank G. Brooks Award
Michael Stephens, an undergraduate researcher in the Fulkerson Lab, presented at the annual, regional meeting of the Northeast-4 district (the states of KY, OH, and MI) of the National Biological Honors Society and won the Frank G. Brooks award for ranking first place in podium presentations. He was presented with a plaque and certificate and provided funds for him to present at the national conference this year. Michael is pictured below with Dr. Eugene Burns, who is the chair of the district.
Crohn's & Colitis Foundation of America AwardSimon P. Hogan, PhD and Artem Barski, PhD are co-investigators with Lee A. Denson, PhD and Yael Haberman Ziv, MD on their joint Senior Research Award entitled, "Leukocyte Immunoglobulin-like receptor B3 in Innate Colonic Inflammation in Pediatric Ulcerative Colitis." This Crohn's & Colitis Foundation of America (CCFA) award represents the successful collaboration between Cincinnati Children's Inflammatory Bowel Disease (IBD) Center and the Divisions of Gastroenterology, Hepatology and Nutrition and of Allergy and Immunology.
Safety Star Award
The Division of Allergy and Immunology was recognized with a Cincinnati Children's Safety Star Award for their commitment and implementation of good safety practices. Pictured below are a few members of the division with our award notice.
National Student Research Forum Awards
Abby Stein, a medical student researcher in the Fulkerson Lab, and Patrick McWeeney, a medical student researcher in the Hogan Lab, won awards at the 55th Annual National Student Research Forum (University of Texas, Medical Branch campus, Galveston, Texas). Abby’s presentation of eosinophil progenitors in experimental asthma won the best poster presentation in the Immunology category, and Patrick’s presentation won the best poster presentation in the Biochemistry and Molecular Biology section. These two medical student researchers were part of Cincinnati Children's Summer Medical Student Respiratory Research Fellowship (SMURRF) program and represented Cincinnati Children’s, the University of Cincinnati and our division well.
Digestive Health Center Pilot and Feasibility Awards
Joseph D. Sherrill, PhD was awarded a Digestive Health Center Pilot and Feasibility Award for his project “Characterization of the Antimicrobial Peptide RNase 7 in Eosinophilic Esophagitis”. Additionally, Simon P. Hogan, PhD is a co-investigator on another awarded Digestive Health Center Pilot and Feasibility Award for the project “Star-related Lipid Transfer (StarD7) in Intestinal Epithelial Barrier Function and Food Sensitization”.
Digestive Health Center Research Symposium Award
Julie Caldwell, a research associate in the Rothenberg Lab, won first for posters at the Digestive Health Center Research Symposium for her project “CDH26: a Functional Integrin-Binding Cadherin Involve in Eosinophilic Gastrointestinal Disorders”.
Congratulations to Dave Morris, a clinical fellow in the Fulkerson Lab, who was awarded a 2014 ARTrust grant entitled “Characterization of eosinophil progenitors (EoPs) in the peripheral blood of pediatric patients with active eosinophilic esophagitis (EoE)”. He is pictured below with Linda Cox, the President of AAAAI, and Dennis Ledford, the past President of AAAAI.
Cincinnati Children’s Blog
Amal H. Assa’ad, MD, Associate Director and Clinical Director of the Division of Allergy and Immunology, was featured in the Cincinnati Children’s Blog with her post “Food Allergy vs. Intolerance: What’s the Difference”.
Rahul D’Mello, a MD, PhD student in the Rothenberg Lab, speaks about his experiences in a University of Cincinnati College of Medicinearticle (pages 19-21) about shaping the next generation of physician-scientists.
Discovery of Impaired Barrier Function in Eosinophilic Esophagitis (PDF)
CURED Foundation Donates $157,000 for Eosinophilic Disorder Treatment and Research (PDF)
Division Director at Cincinnati Children's Elected AAAS Fellow (PDF)
Second Annual CURED Patient Research ConferenceThe second annual CURED Patient Research Conference was a huge success. There were about 235 in attendance on Friday, and 160 on Saturday. There were 26 states represented and three countries. The attendees heard from the leading experts around the world, including our very own experts from Cincinnati Children's and the Cincinnati Center for Eosinophilic Disorders. CURED support helps further our mission to find a cure for eosinophilic disorders.
Discovery by Israeli and American Researchers May Lead to New Treatments for Allergic Diseases (PDF)
Congratulations to Ting Wen, PhD, a postdoctoral fellow in the Rothenberg Lab for winning the second-place prize at the third annual Ohio River Valley Cytometry Association's Imaging and Cytometry Research Day.
Pediatric Immunologists' Drive Efforts for SCID Screening for Newborns (PDF)
Interview with the Authors: Mechanism of Siglec-8-Mediated Cell Death
Epinephrine: It's Still Our Fail Safe
Despite Shots, Peanut Allergy Kills Teen
New Leadership for Division Research Simon P. Hogan, PhD was recently appointed as the Director of Research of the Division of Allergy/Immunology. He joins the Division Director, Marc E. Rothenberg, MD, PhD, and Amal H. Assa'ad, MD, the Associate Division Director, in leading the division in its mission to improve the health of children with allergic and immune conditions through innovative research, outstanding clinical care and education of the current and next generation of leaders in healthcare and research. In this new role, Hogan will strengthen the guidance available to division researchers with his hands-on approach and will be an advocate for process improvements that facilitate quality research.
A Patch to Treat Peanut Allergies in Works
Faculty Do Not Support Claim that Eosinophilic Disorders are Related to GMO CornA recent article in Elle magazine has speculated that GMO (genetically modified organism) corn can promote eosinophil-related diseases. There are statements in this article that are scientifically inaccurate in our opinion. The magazine article describes the presence of eosinophils in a nasal swab. This finding by itself is not indicative of an eosinophilic disorder. The presence of eosinophils in a nasal swab specimen is a common finding in patients with hay fever (allergic rhinitis), a disease process that has been well established to be caused by respiratory allergies. Further, it is our expert opinion that there is not sufficient knowledge or scientific foundation to warrant the claim in this article that eosinophilic disorders arise from GMO corn.
This statement is released by all of the Cincinnati Children's faculty mentioned in the article. Marc E. Rothenberg MD, PhD; Amal H. Assa'ad, MD; Simon P. Hogan, PhD; Karl von Tiehl, MD
A recent research study extends our prior findings about connective tissue disorders and eosinophilic gastrointestinal disorders (Abonia et al.) and provides further rationale for our current Losartan trial.
A Bad Alliance: Rare Immune Cells Promote Food-Induced Allergic Inflammation in the Esophagus.
The Cincinnati Center for Eosinophilic Disorders' research is opening up new avenues for research by others, as evidenced by this recent Nature Medicine publication by Noti et al. being founded in our work.
Rigorous MSTP Program Teaches Both Sides of Research/Clinical EquationRead about the MSTP Program and how Rahul D'Mello, part of the University of Cincinnati's MSTP program, is currently completing his PhD in the lab of our division's director, Marc E. Rothenberg, MD, PhD.
2013 Rome Foundation Research AwardA postdoctoral research fellow alumni of the Rothenberg Lab, Maria Vicario Perez, PhD, received a Rome Foundation Research Award for 2013.
Mother and Son Plan to Climb Mt. Kilimanjaro for a Cause
Read about a mother an son who will be climbing Mount Kilimanjaro to help raise awareness and find a cure for eosinophilic esophagitis.
In recognition of her dedication in advancing the specialty by her work in food allergy and science, the American College of Allergy, Asthma & immunology (ACAAI) unanimously voted Amal H. Assa'ad, MD to receive the ACAAI Woman in Allergy award for 2013.
Amal H. Assa'ad, MD comments in a news article and video regarding a research study of how cleaning a child's pacifier by mouth (spit) may reduce the child's risk of allergies.
Patricia Fulkerson Receives 2013 ARTrust Faculty Development Award Medical School Faculty
Patricia C. Fulkerson, MD, PhD was awarded a 2013 ARTrustTM Faculty Development Award by the American Academy of Allergy, Asthma and Immunology (AAAAI). This funding supports her research investigating the regulation of eosinophil progenitors by Toll-like receptors.
UC Students Go Bald for Cancer Research
One of our graduate students, Rahul D'Mello, helped raise funds for childhood cancer research with other students at the University of Cincinnati by having his head shaved during the annual St. Baldrick's Day celebration.
Vincent A. Mukkada, MD, has joined the Division of Gastroenterology, Hepatology and Nutrition and Cincinnati Center for Eosinophilic Disorders (CCED) at Cincinnati Children’s as an Assistant Professor of Pediatrics. As a physician for the CCED, Mukkada will provide clinical diagnosis and care for children with eosinophilic disorders.
2013 HOPE Pilot Research Grants
The American Partnership for Eosinophilic Disorders (APFED) is proud to support two HOPE Pilot research grants in 2013, one of which was awarded to Yui-Hsi, Wang, PhD. His research proposal will test the hypothesis that the cytokine IL-25 activates a particular population of lymphoid cells, the resident ILC2 population, to induce eosinophil accumulation. This work will help in the understanding of what drives eosinophil accumulation in the gastrointestinal tract.
Eleanor Garrow Joins Cincinnati Center for Eosinophilic Disorders Eleanor Garrow has joined the Cincinnati Center for Eosinophilic Disorders (CCED) at Cincinnati Children’s as senior specialist for program management. In this role, Garrow will direct implementation of strategic planning; guide the team by developing processes to drive clinical, quality and research improvements; and work with individuals, families and public groups to increase support and awareness of eosinophilic disorders.
Our division's director Marc E. Rothenberg, MD, PhD and fellowship program director Kimberly A. Risma, MD, PhD were named among Cincy Magazine's list of Best Doctors for 2013.
Leading Food Allergy Organizations Announce Completion of Merger and Introduce New Name Read about the merger of the Food Allergy Initiative (FAI) and Food Allergy & Anaphylaxis Network (FAAN) into FARE (Food Allergy Research & Education).
Frank Sasinowski, Vice Chair of the Board of Directors for NORD, mentions his work and Keynote Speech at the CURED EGID Research Symposium in the FDA Law Blog.
CURED (Campaign Urging Research for Eosinophilic Disease) EGID (Eosinophilic Gastrointestinal Disorder) Research Symposium
Children's director is Red Cross heroRead more about the work of our division's business director, Kevin Titus, as he answer questions about his important work as a Red Cross public affairs manager.
CURED Foundation Makes Generous Donation of $150,000 to the Cincinnati Center for Eosinophilic Disorders Research Efforts. This brings the total amount of money donated to the Center by CURED to $2,114,000 in the past 10 years.
Santa Jeremy Ono Named President of the University of CincinnatiThe Board of Trustees of the University of Cincinnati voted unanimously to appoint Santa Ono, PhD as President of the University of Cincinnati. Ono had been appointed Interim President at the University of Cincinnati in August 2012, following the resignation of Gregory H. Williams. Ono first arrived at the University of Cincinnati in 2010, serving two years as the Senior Vice President for Academic Affairs and Provost. As provost, he led the development of an academic master plan aligned to the university’s strategic plan, “UC2019: Accelerating Our Transformation.” The academic master plan, unveiled in May 2012, included an initial investment of about $10 million toward long-term strategic goals set for completion in the University of Cincinnati's bicentennial year of 2019. President Ono is one of a handful of university presidents in the nation who have fully embraced social media and has more than 6,700 followers of his Twitter feed: @PrezOno.
At Cincinnati Children's Recognition Dinner, honoring employees with 10- to 50-year service anniversaries, Amal H. Assa'ad, MD and Thomas J. Fischer, MDfrom our division were honored for their 20 years and 35 years, respectively, of dedicated service at Cincinnati Children's.
Springdale boy shows super strength, spiritRead about Jordan Scott and the Eosinophilic Avengers who walked on Saturday, October 20, 2012 at Cincinnati Walks for Kids.
Amal H. Assa'ad, MD, having led the Allergy/Immunology Fellowship Program as Fellowship Director for 17 years with dedication and excellence, has passed this role onto Kimberly A. Risma, MD, PhD. We look forward to Amal H. Assa'ad's continued involvement in teaching our future allergists in this combined pediatric and adult fellowship program (via partnership with the University of Cincinnati) as this program is an integral part of our division's mission to improve the health of children with allergic and immune conditions through innovative research, outstanding clinical care, and education of the current and next generation of leaders in healthcare and research.
CCED and CEFC Annual Interactive Eosinophilic Research Lab DayMarc Rothenberg, MD, PhD and other pediatrics researchers in his lab and the Cincinnati Center for Eosinophilic Disorders (CCED) hosted their annual interactive eosinophilic research interactive lab day in collaboration with the Cincinnati Eosinophilic Family Coalition (CEFC).
Clinical Director elected to the AAAAI Board of DirectorsOur division's clinical director, Amal H. Assa'ad, MD, was elected to the American Academy of Asthma, Allergy and Immunology (AAAAI)'s Board of Directors.
CURED Foundation Makes Generous Donation of $150,000 to Support Eosinophilic Research.
For Teen With Eosinophils of the Esophagus, Food Is ForbiddenIn this news article, Marc Rothenberg, MD, PhD, comments on how dietary restrictions can be disabling and that people with eosinophilic disorders have been shown to have the lowest quality of life as compared to a variety of other pediatric chronic diseases.
Researchers Evaluate Dietary Regimens of Allergic DiseaseMarc Rothenberg, MD, PhD, and other pediatrics researchers in the Division of Allergy and Immunology have taken a critical step in improving patient care by evaluating the comparative effectiveness of current dietary therapies (elemental diet, six-food elimination diet, skin test-directed elimination diet) and the utility of skin test-directed diets in food reintroductions for eosinophilic esophagitis. The study found that while all three of the evaluated dietary therapies are effective in decreasing activity of the disease, the elemental diet is superior and using skin testing to direct diets was not helpful compared with empiric removal of certain ‘high risk’ foods.
Israel's Top 10 Advances in AsthmaIn this news article, Ariel Munitz, PhD is mentioned for his recent research collaborative efforts in designing a small antibody fragment that may be able to target the cause of asthma and allergies by targeting a receptor protein on the surface of mast cells.
How Do You Tell the Difference Between Seasonal Allergies and a Cold?In this news article, Michelle B. Lierl, MD, comments on how to distinguish between allergies and the common cold, which is important for getting proper treatment.
Researchers Identify New Regulator in Allergic DiseasesMarc Rothenberg, MD, PhD, and other pediatrics researchers in the Division of Allergy and Immunology have taken a critical step in understanding how allergic reactions occur after identifying a genetic signature for regulation of a key immune hormone, interleukin 13 (IL-13). The study identifies that microRNA 375 is regulated by IL-13, and in turn regulates how IL-13 induces pro-allergic changes, particularly in epithelial cells in the lung and esophagus. The data support a role for microRNA 375 in asthma and eosinophilic esophagitis.
Passing of Our Friend and Mentor Dr. Leonard I. BernsteinOur friend, mentor, and beloved colleague. Dr. Leonard Bernstein, a pioneer in the Allergy/Immunology field and founder of Allergy/Immunology in Cincinnati passed away at age 88, on March 26, 2012. Dr. Bersnstein was the beloved husband of Miriam G. Bernstein, devoted father of Dr. David (Cheryl) Bernstein, Dr. Susan (Howard Ain) Bernstein, Dr. Jonathan (Lisa) Bernstein & the late Ellen B. Ganson (Michael Ganson), dear brother of the late Leah Geber, loving grandfather of Daniel (Jaime Aronson) & William Bernstein, Aaron, Joel (Alyce Baier), Rachel & Marisa Ellison, Jason & Andrew (Emily Sanchez) Ain, Adam, Sarah & Philip Ganson & Alison, Joshua, Rebecca & Caren Bernstein.
With the passing of Dr. I. Leonard Bernstein, his family, the University of Cincinnati, the city of Cincinnati and the field of Allergy and Immunology have lost a great father, friend and a mentor.
Memorial contributions can be made to the Ellen B. Ganson Fund c/o Rockwern Academy, 8401 Montgomery Rd., Cinti, OH 45236 or the Bernstein Endowment Fund for Allergy Research & Education at the U.C. Foundation, P.O. Box 670544, Cinti, OH 45321.
Genetic Marker for Painful Food Allergy Points to Improved Diagnosis, TreatmentMarc Rothenberg, MD, PhD, and other pediatrics researchers in the Division of Allergy and Immunology have identified a genetic signature for a severe, often painful food allergy – eosinophilic esophagitis – that could lead to improved diagnosis and treatment for children unable to eat a wide variety of foods. The researchers found that EoE was associated with 32 differentially regulated microRNAs and distinguishable from the non-eosinophilic forms of esophagitis (such as reflux disease). Esophageal eosinophil levels correlated significantly with expression of the most increased microRNAs, miR-21 and miR-223, and most decreased, miR-375. MiR-223 was also one of the most increased microRNAs in the plasma, along with miR-146a and miR-146b. Notably, the expression of microRNAs dysregulated in patients with active EoE was normalized in patients with EoE who responded to steroid treatment. This suggests a significantly specific microRNA signature for disease activity points to its promise for use as a biomarker for EoE.
Asthma Worse for Children in Single-Parent HomesTerri Moncrief, MD, faculty member of the Division of Allergy and Immunology at Cincinnati Children’s, was the lead author of this study, which found that children from single-parent homes admitted to the hospital for asthma or wheezing are 50 percent more likely to return to the hospital within a year than children from two-parent homes.
Keynote Presentation at Upcoming Allergy Drug Discovery and Development Conference Marc Rothenberg, MD, PhD, Director of the Division of Allergy and Immunology at Cincinnati Children's Hospital Medical Center, will be giving a keynote presentation entitled “Breakthroughs in understanding the pathogenesis of the new allergic disease eosinophilic esophagitis and implications for drug development,” at the Allergy Drug Discovery and Development Conference to be held on January 30-31, 2012 in San Diego, CA by GTC.
CURED Foundation Continues Support of Eosinophilic ResearchThe CURED Foundation (Campaign Urging Research for Eosinophilic Disease) has pledged another $100,000 to help fund groundbreaking research at Cincinnati Children’s. The gift was made possible by the Vivint Gives Back Project, which hosted a Facebook-based competition among nonprofit organizations in the United States and Canada. The CURED Foundation won a $100,000 prize after receiving the most online votes in their region.
Mepolizumab Appears Beneficial in Children with Eosinophilic EsophagitisThis news article discusses the promising results of the recently reported clinical trial of the anti-IL-5 monoclonal antibody mepolizumab, which was conducted by Amal H. Assa’ad, MD and colleagues and based on prior pre-clinical and proof-of-concept studies previously conducted by divisional faculty.
Smithfield Girl Undergoing Treatment for Rare DiseaseMarc Rothenberg, MD, PhD, comments on eosinophilic esophagitis as a growing medical problem in this article about a little girl with eosinophilic esophagitis who travels to the Cincinnati Center for Eosinophilic Disorders for treatment.
Eosinophilic Esophagitis: Updated Consensus Recommendations For Children and AdultsThe first consensus recommendations for eosinophilic esophagitis were derived from the first symposium held by The International Gastrointestinal Eosinophil Researchers (TIGER), which was comprised of several members of the CCED faculty. These guidelines were published in 2007 as Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.
These original consensus guidelines for eosinophilic esophagitis were reviewed and updated in 2011 and published as Eosinophilic esophagitis: updated consensus recommendations for children and adults, with members of the division faculty contributing in this endeavor.
Immunobiology Award RecipientAmanda Beichler, a predoctoral candidate in our division, was awarded first prize for the most outstanding poster in the competition held at Cincinnati Children’s Immunobiology Graduate Program Retreat. Her work was titled “Myeloid RelA/p65 and STAT-6 regulation ofCCL11 and eosinophilic inflammation in colitis.
MTV Series True Life: I’m Allergic to EverythingMarc Rothenberg, MD, PhD appears in the MTV True Life Series “I’m Allergic to Everything” episode in the segment featuring a young man with eosinophilic esophagitis.
CURED Foundation Makes Generous DonationEllyn, Jori and Fred Kodroff and the CURED Foundation once again showed their generosity by donating $150,000 to our research efforts in the CCED and on eosinophilic disorders on June 6, 2011 in the Division of Allergy and Immunology office. Their commitment, drive and determination to find a cure has made a significant difference in advancing research and our understanding of eosinophilic disorders and will help to change the outcome for families around the world.
Study Reveals Long-term Outcomes for Children with New Food Allergy Related Disease Eosinophilic EsophagitisThe first study of its kind to examine the long-term natural history of an emerging new disease, eosinophilic esophagitis, has identified factors associated with complications and reveals that children with the disorder have persistent disease into adulthood. The study, published online June 3 in the Journal of Allergy and Clinical Immunology, was conducted by researchers at Cincinnati Children’s Hospital Medical Center, including Marc Rothenberg, MD, PhD. They studied hundreds of people diagnosed with high counts of esophageal eosinophils before eosinophilic esophagitis was known to be a separate disease.Read more on the study.
AGA-Stuart Brotman Student Research Fellowship Award RecipientAkanksha Mishra, a recent high school graduate and previous summer research student in the Division, has received the American Gastroenterological Association (AGA) Research Foundation's 2011 AGA-Stuart Brotman Student Research Fellowship Award. This award provides funds for her to continue research in the Division this summer.
Allergy or Cold? Ohio Expert Offers Tips to Help ParentsIn this news article, Karl von Tiehl, MD comments on how to distinguish between allergies and the common cold, which is important for getting proper treatment.
How to Tell if You Have Symptoms of Allergies or a ColdDr. Karl von Tiehl, an allergist at Cincinnati Children’s, explains the difference between allergies and colds on a local news segment.
American Association of Immunologists (AAI) Award RecipientPatricia Fulkerson, MD, PhD, a fellow in training, has received the 2011 AAI-Life Technologies Trainee Achievement Award in recognition of her promise in the field of immunology. The award was presented during the 98th AAI annual meeting in San Francisco.
DHC Award RecipientJoseph Sherrill, PhD, a fellow in training, received first place in the poster competition held at Cincinnati Children’s Digestive Health Center Annual Scientific Retreat for his work, titled “Dysregulation of the Desmosomal Cadherin Desmoglein-1 in Eosinophilic Esophagitis.”
New Pamphlet Guides Patients on Food AllergiesThe National Institute of Allergy and Infectious Diseases (NIAID) has released a pamphlet that can be shared with patients, offering a comprehensive overview of food allergies. Download the pamphlet.
With Children and Food Allergy Diagnoses, Thoroughness is KeyIn this news article summarizing current knowledge about food allergies and their diagnosis and treatment, Amal H. Assa’ad, MD, comments on the over diagnosis of food allergies, the insufficiency of a sensitized immune reaction (such as a rash in response to a skin prick test) to the diagnosis food allergy, and the best remedy for an allergic reaction to food.
CURED Foundation Makes Generous DonationEllyn, Jori and Fred Kodroff and the CURED Foundation donated $75,000 to our research efforts on eosinophilic disorders in a check presentation in the Division of Allergy and Immunology office. Their commitment, drive and determination to find a cure has made a significant difference in advancing research and our understanding of eosinophilic disorders and will help to change the outcome for families around the world. http://www.curedfoundation.org/
Division Faculty Plays Key Role in Report − Guidelines for Food Allergy Testing RevisedAmal H. Assa’ad, MD, comments on the need for consistent follow-up for food allergy in this article about the insufficiency of using skin prick and blood tests alone for food allergy diagnosis. See also Cincinnati Children’s summary of this article called Food Allergy Testing: Skin Pricks May Just Scratch the Surface.
Local Family Raises Donations for Eosinophilic ResearchThe Kramer family and friends organized a golf tournament in Cincinnati, raising $4,500 for the Cincinnati Center for Eosinophilic Disorders. The initiative came from 5-year-old Arianna. We celebrated her enthusiasm, spirit and gift at a check presentation in the Division of Allergy and Immunology offices. We are constantly made aware of and humbled by the strength, determination and kindness of children living with eosinophilic disorders.
Way to Turn Off Immune System’s Allergic Reaction DiscoveredThe findings provide hope that the body could be trained to tolerate food allergies that lead to roughly 300,000 emergency room visits and 100 to 200 deaths each year.
FDA Drug Safety Communication: Eosinophilic Pneumonia Associated with the Use of Cubicin (daptomycin)The FDA informs patients and healthcare professionals about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous antibacterial drug.
Doctor at Cincinnati Children’s Receives Prestigious NIH MERIT Award to Extend Research of Eosinophilic DisordersMarc Rothenberg, MD, PhD, director of the Division of Allergy and Immunology at Cincinnati Children’s, has received an NIH MERIT Award to extend funding of his long-standing investigation into “Regulation of Gastrointestinal Eosinophils.”
Angels for Eosinophilic Research: Dallas Families Unite with Hopes to End Suffering Caused By Eosinophilic Gastrointestinal DisordersAngels For Eosinophilic Research is dedicated to raising money for research for a cure for Eosinophilic (EOS) Disorders. They hope to bring awareness to the world of the strength, faith, and courage of every person fighting this disease. The Angels for Eosinophilic Research fundraising and golf tournament in Dallas, Texas raised $130,000 dollars in their first ever event. The Zicarelli and Angel families, with their sons Luke and Zeke leading the way, combined efforts to raise money for research here at the Cincinnati Center for Eosinophilic Disorders (CCED). The CCED team and hospital officials came together on July 15, 2010 to accept their generous donation and to celebrate their great accomplishment.
NIH Expands Food Allergy Research ProgramThe National Institutes of Health announced that the funding for the Consortium of Food Allergy Research (CoFAR) will be renewed with a five-year, $29.9 million grant. CoFAR will continue to foster new approaches to prevent and treat food allergies and also expand in scope to include research on the genetic causes underlying food allergy and studies of food allergy-associated eosinophilic gastrointestinal diseases. A portion of this funding will allow Marc Rothenberg, MD, PhD, to further investigate the genetics of eosinophilic esophagitis and its treatment.
Endowment Boosts Female ResearchersThe Charlotte R. Schmidlapp Women’s Scholars Program, which awarded Kimberly Risma, MD, PhD, the Schmidlapp award last year, has received a $2 million endowment.
Rare Disease Makes Scottsdale Boy Reject Solid FoodMarc Rothenberg, MD, PhD, comments on the state of research and lives of children with eosinophilic gastrointestinal disorders in this article about a Cincinnati Children’s patient.
National Registry to Track Eosinophilic DisordersA $1.6 million federal economic stimulus grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases has helped to launch the Registry for Eosinophilic Gastrointestinal Disorders (REGID). “This registry provides the infrastructure necessary for understanding and treating eosinophilic disorders at a national level, and ultimately, at the international level,” says Marc Rothenberg, MD, PhD, the principal investigator and developer of REGID. The registry is the first of its kind for eosinophilic disorders and will allow participating centers to build a database of research-accessible clinical information for thousands of patients coping with eosinophilic disorders. The registry will help researchers find patients for clinical trials, compare treatment outcomes and expand knowledge about these unusual conditions.
Gene Site Found for a Children’s Food Allergy
Marc Rothenberg, MD, PhD, and other pediatrics researchers in the Division of Allergy and Immunology have identified the first major gene location responsible for a severe, often painful type of food allergy, eosinophilic esophagitis, that leaves its victims unable to eat a wide variety of foods. This type of food allergy, eosinophilic esophagitis, also may cause weight loss, vomiting and heartburn. The gene site linked to eosinophilic esophagitis plays a key role in inflammation.
After performing a genome-wide association study, the study team found eosinophilic esophagitis was linked to a region of chromosome 5 that includes two genes. The likely culprit is the gene TSLP, which has higher activity levels in children with eosinophilic esophagitis compared to healthy subjects. In addition, TSLP has been previously linked to allergic inflammatory diseases, such as asthma and the skin inflammation atopic dermatitis.
The shown image is a Manhattan plot of the meta-analysis of the patient cohorts of Cincinnati Children’s and the Children’s Hospital of Philadelphia. Each dot represents a single-nucleotide polymorphism, and the higher the –log10 p-value (y-axis value) the more significant the association of the genetic polymorphism with eosinophilic esophagitis.
Food Allergy Sufferers find Socializing TrickyKarl von Tiehl, MD, comments on the effects of food allergies on the human body. Read the article.
American Academy of Allergy, Asthma & Immunology (AAAAI) Abstract Award RecipientCharles DeBrosse, MD, a fellow in training, has received the 2010 American Academy of Pediatrics Section on Allergy and Immunology Outstanding Pediatric Abstract Award. The award was announced during the International AAAAI meeting in New Orleans. DeBrosse presented a talk, “The ‘Epidemic’ of Eosinophilic Esophagitis (EE) is due to Increased Recognition of a Chronic Disorder.”
Managing Food Allergies During Holiday SeasonKarl von Tiehl, MD, gives suggestions on managing your child’s food allergies during this holiday season. Read the article.
Allergies Linked to Delaying Solid FoodsLi Zuo, MD, commented on delaying introduction of solid foods.
ACAAI: Gelatin a Culprit in Some Vaccine ReactionsLi Zuo, MD, commented on delaying introduction of solid foods. Read the article.
Food Allergy & Anaphylaxis Network (FAAN) Committed to Food Allergy Research and Awards Grants to Two Cincinnati Children’s ResearchersThe Division of Allergy and Immunology’s Marc Rothenberg, MD, PhD, director, and Simon Hogan, PhD, assistant professor, are two of six leading scientists across the country to share a $1.1 million grant for food allergy research. The funding is provided by the Food Allergy & Anaphylaxis Network (FAAN) and represents the largest commitment since FAAN’s research grant program began in 2004. To date, more than $4.3 million has been awarded to scientists who are studying the areas of epidemiology, etiology, treatment and prevention of food allergy and anaphylaxis.
The six scientists are working on potential food allergy vaccines and therapies, painstakingly studying anaphylaxis to better understand it, and trying to solve the mysteries of food allergy development. Rothenberg’s project focuses on developing new diagnostic and treatment approaches for eosinophilic esophagitis, an emerging type of food allergy and disorder characterized by the infiltration of a large number of eosinophils (a type of white blood cell) in the esophagus. He hopes to uncover the molecular basis for eosinophilic esophagitis.
Hogan is studying anaphylaxis by comparing the levels of IL-9, a factor in the body thought to be associated with anaphylaxis, in children who are at risk for this life-threatening reaction to levels in children who are not at risk. This information could help in the diagnosis of food-triggered, life-threatening anaphylaxis.
Other projects include a study of the association between vitamin D and the development of food allergy among children; a study of the use of DNA vaccines to suppress the allergic response toward the major shrimp allergen in an effort to design therapeutic vaccines for food allergy; and developing a new therapeutic approach to peanut allergy through a vaccine.
Each of the six projects is funded in the range of $50,000 to $150,000 per year for up to two years. Read the article.
Our division's clinical trials team is dedicated to bringing cutting-edge therapies to our child and adult patients.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center